Skip to content

Author

O. Mironenko

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

Comparative efficacy and safety of prolgolimab and nivolumab in first-line therapy for metastatic or unresectable melanoma: a systematic review, matching-adjusted indirect comparison, and cost-effectiveness analysis

Background . Metastatic and unresectable cutaneous melanoma (MM/uRCM) is an aggressive malignancy associated with high mortality due to its pronounced metastatic potential. Immune checkpoint inhibitors are used to treat MM/uRCM in the Russian Federation. These inhibitors include nivolumab and prolgolimab, which...

I. Utyashev, I. Myslevtsev, O. Mironenko et al. · 0 citations
Aug 2026

[Comparison of 6-Year Outcomes after Open Surgery, Successful Laparoscopic Adhesiolysis, and Non-Operative Management of Adhesive Small Bowel Obstruction].

OBJECTIVE To compare short- and long-term outcomes of open surgery, laparoscopic adhesiolysis and non-operative management in patients with adhesive small bowel obstruction. MATERIAL AND METHODS A multiple-center retrospective cohort study included 366 patients with small bowel obstruction (SBO) treated across seven...

A. E. Tyagunov, B. Abdulkarim, O. Mironenko et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.